# Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery

> **NCT02447796** · PHASE4 · UNKNOWN · sponsor: **Baskent University** · enrollment: 48 (estimated)

## Conditions studied

- Arteriovenous Fistula

## Interventions

- **DRUG:** Propofol
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT02447796
- **Lead sponsor:** Baskent University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2015-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447796, "Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02447796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*